218 related articles for article (PubMed ID: 38403433)
1. The immune system of prokaryotes: potential applications and implications for gene editing.
Liu S; Liu H; Wang X; Shi L
Biotechnol J; 2024 Feb; 19(2):e2300352. PubMed ID: 38403433
[TBL] [Abstract][Full Text] [Related]
2. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
Mojica FJM; Montoliu L
Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.
Liu TY; Doudna JA
J Biol Chem; 2020 Oct; 295(42):14473-14487. PubMed ID: 32817336
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
Xu Z; Li Y; Li M; Xiang H; Yan A
Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing.
Hossain MA
Prog Mol Biol Transl Sci; 2021; 178():63-83. PubMed ID: 33685600
[TBL] [Abstract][Full Text] [Related]
7. Structural biology of CRISPR-Cas immunity and genome editing enzymes.
Wang JY; Pausch P; Doudna JA
Nat Rev Microbiol; 2022 Nov; 20(11):641-656. PubMed ID: 35562427
[TBL] [Abstract][Full Text] [Related]
8. Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System.
Kolesnik MV; Fedorova I; Karneyeva KA; Artamonova DN; Severinov KV
Biochemistry (Mosc); 2021 Oct; 86(10):1301-1314. PubMed ID: 34903162
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases.
Garcia-Robledo JE; Barrera MC; Tobón GJ
Int Rev Immunol; 2020; 39(1):11-20. PubMed ID: 31625429
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Genome-Engineering Strategies.
Boti MA; Athanasopoulou K; Adamopoulos PG; Sideris DC; Scorilas A
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672870
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas12a: Functional overview and applications.
Paul B; Montoya G
Biomed J; 2020 Feb; 43(1):8-17. PubMed ID: 32200959
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
Bhatia S; Pooja ; Yadav SK
Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing.
Ferreira P; Choupina AB
Mol Biol Rep; 2022 Jul; 49(7):7079-7086. PubMed ID: 35716290
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
16. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
[TBL] [Abstract][Full Text] [Related]
17. Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.
Liu Z; Liu J; Yang Z; Zhu L; Zhu Z; Huang H; Jiang L
Biotechnol Adv; 2023 Nov; 68():108241. PubMed ID: 37633620
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
Khanzadi MN; Khan AA
J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
[TBL] [Abstract][Full Text] [Related]
19. A decade of discovery: CRISPR functions and applications.
Barrangou R; Horvath P
Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
